Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Liver X receptors (LXRs) are nuclear receptors that play a central role in regulating cholesterol, fatty acid, and glucose homeostasis. They function as transcription factors activated by endogenous ligands—primarily oxysterols, which are oxidized derivatives of cholesterol. LXRs act as cellular cholesterol sensors and are considered promising targets for treating metabolic disorders. Activation may also promote hepatic steatosis/hypertriglyceridemia due to increased lipogenesis.
Upon binding their ligands, LXRs form heterodimers with RXR isoforms. These complexes bind to liver X response elements in target gene promoters to regulate transcription, modulating genes involved in cholesterol, fatty acid, and glucose homeostasis, as well as inflammation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Liver X receptor (LXR).